HT
HIMS icon

HAP Trading’s Hims & Hers Health HIMS Stock Holding History

HAP Trading’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$101K Sell
37,700
-14,000
-27% -$717K 0.01% 490
2025
Q2 		$229K Buy
51,700
+14,500
+39% +$655K 0.02% 304
2025
Q1 		$283K Buy
37,200
+20,500
+123% +$762K 0.03% 260
2024
Q4 		$37.8K Buy
+16,700
New +$414K ﹤0.01% 495
2024
Q1 		– Sell
-282,600
Closed -$113K – 866
2023
Q4 		$113K Sell
282,600
-312,800
-53% -$2.31M 0.02% 351
2023
Q3 		$1.64M Sell
595,400
-4,500
-0.8% -$33.5K 0.26% 85
2023
Q2 		$747K Buy
+599,900
New +$5.95M 0.13% 143
2022
Q4 		– Sell
-13,300
Closed -$10K – 1675
2022
Q3 		$10K Buy
+13,300
New +$80.1K ﹤0.01% 1329
2021
Q4 		– Sell
-23,200
Closed -$68K – 2666
2021
Q3 		$68K Buy
23,200
+12,400
+115% +$105K ﹤0.01% 1401
2021
Q2 		$35K Sell
10,800
-9,100
-46% -$108K ﹤0.01% 1609
2021
Q1 		$55K Buy
+19,900
New +$334K ﹤0.01% 1141

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HAP Trading's HIMS Position: Q2 2025 in Review

HAP Trading sold out of Hims & Hers Health (HIMS) in Q2 2025, closing a stake of 16,059 shares — an estimated $726K sold.

HAP Trading first reported a position in HIMS in Q1 2021 and held it in 5 quarters. The position peaked at $2.91M in Q3 2023. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

  • HAP Trading reported no remaining Hims & Hers Health position as of Q2 2025 after selling out during the quarter.
  • HAP Trading sold 16,059 Hims & Hers Health shares in Q2 2025, an estimated $726K.
  • HAP Trading first reported a position in Hims & Hers Health in Q1 2021 and held it in 5 quarters.
  • HAP Trading's Hims & Hers Health position peaked at $2.91M in Q3 2023.
  • 510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on HAP Trading's 13F filing for Q2 2025, filed 13 Aug 2025.